Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
10.09
-0.06 (-0.59%)
Apr 25, 2025, 2:45 PM CST

Walvax Biotechnology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Cash & Equivalents
3,7644,3653,8733,4431,962
Upgrade
Cash & Short-Term Investments
3,7644,3653,8733,4431,962
Upgrade
Cash Growth
-13.77%12.68%12.49%75.54%-17.62%
Upgrade
Accounts Receivable
2,4103,1013,5772,4812,004
Upgrade
Other Receivables
58.8114.18416.13774.86304.77
Upgrade
Receivables
2,4683,2153,9933,2552,308
Upgrade
Inventory
752.591,035995.81873.59483.56
Upgrade
Other Current Assets
82.22119.2186.25107.9426.77
Upgrade
Total Current Assets
7,0678,7338,9487,6804,780
Upgrade
Property, Plant & Equipment
4,0793,7683,1612,6041,590
Upgrade
Long-Term Investments
1,6381,0571,2921,4911,605
Upgrade
Goodwill
33.6633.6633.6633.6633.66
Upgrade
Other Intangible Assets
1,0351,0861,167434.98271.68
Upgrade
Long-Term Accounts Receivable
7.27----
Upgrade
Long-Term Deferred Tax Assets
104.56103.44124.84168.01138.55
Upgrade
Long-Term Deferred Charges
513.86473.48309.381,022890
Upgrade
Other Long-Term Assets
246.62333.54300.2240.63329.41
Upgrade
Total Assets
14,72415,58915,33613,6749,638
Upgrade
Accounts Payable
1,5681,8051,8361,258607.79
Upgrade
Accrued Expenses
549.81722.051,189754.71497.41
Upgrade
Short-Term Debt
-320.2797.1831040
Upgrade
Current Portion of Long-Term Debt
38.988.79---
Upgrade
Current Portion of Leases
7.8521.8823.354.6-
Upgrade
Current Income Taxes Payable
-14.1319.472.0368.54
Upgrade
Current Unearned Revenue
106.18160.4766.7835.299.68
Upgrade
Other Current Liabilities
99.4151.25276.22870.61198.55
Upgrade
Total Current Liabilities
2,3703,2043,5093,2351,422
Upgrade
Long-Term Debt
433.34434.9314.24--
Upgrade
Long-Term Leases
11.7720.627.741.06-
Upgrade
Long-Term Unearned Revenue
278.44423.33404.53344.3256.18
Upgrade
Long-Term Deferred Tax Liabilities
55.9168.7190.9494.56112.27
Upgrade
Other Long-Term Liabilities
6742.08---
Upgrade
Total Liabilities
3,2164,1944,3463,6751,790
Upgrade
Common Stock
1,5991,6071,6071,6011,546
Upgrade
Additional Paid-In Capital
4,5494,9004,9654,7723,262
Upgrade
Retained Earnings
3,1102,9842,5801,8951,546
Upgrade
Treasury Stock
--358.63-286.42--
Upgrade
Comprehensive Income & Other
171.28217.18217.18216.33190.88
Upgrade
Total Common Equity
9,4309,3499,0848,4846,545
Upgrade
Minority Interest
2,0782,0461,9061,5151,303
Upgrade
Shareholders' Equity
11,50811,39510,9909,9997,848
Upgrade
Total Liabilities & Equity
14,72415,58915,33613,6749,638
Upgrade
Total Debt
491.94806.42462.51315.6740
Upgrade
Net Cash (Debt)
3,2723,5583,4113,1281,922
Upgrade
Net Cash Growth
-8.05%4.31%9.06%62.77%-19.30%
Upgrade
Net Cash Per Share
2.052.222.131.991.23
Upgrade
Filing Date Shares Outstanding
1,5991,5991,6011,6011,546
Upgrade
Total Common Shares Outstanding
1,5991,5991,6011,6011,546
Upgrade
Working Capital
4,6975,5295,4404,4453,358
Upgrade
Book Value Per Share
5.905.855.675.304.23
Upgrade
Tangible Book Value
8,3618,2307,8838,0166,239
Upgrade
Tangible Book Value Per Share
5.235.154.925.014.04
Upgrade
Buildings
953.95948.5767.91541.68487.84
Upgrade
Machinery
2,1962,0931,5801,235930.76
Upgrade
Construction In Progress
2,1141,6451,5091,527762.51
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.